The Center for Business Intelligence continues its tradition of bringing together the nation’s leading compliance officers to discuss strategies for ensuring compliance in promotional activities on June 17-18, 2008 at the Sheraton National Hotel, Arlington, VA.
In 2007, the medical device industry came under tremendous scrutiny due to the deferred prosecution agreements in the orthopedics industry. At this event, hear directly from three CCO’s involved in the DPA’s including Zimmer, Smith & Nephew, and Biomet, Inc. Additionally, hear from Smith & Nephew’s Federal Monitor, David Samson, Senior Partner at Wolff and Samson, and Former Attorney General, New Jersey, on the ongoing monitoring and Corporate Integrity Agreements that resulted from these agreements.
Featured Government Perspectives From:
- U.S. Food and Drug Administration
- Office of the United States Attorney for the Eastern District of Pennsylvania
- Office of the United States Attorney for the District of Massachusetts
- Office of the United States Attorney for the District of New Jersey
PLUS! Engage in ground-breaking, confidential discussions on the strategic issues and challenges CCOs are facing today at CBI’s Invitation-Only Medical Device and Diagnostics Chief Compliance Officer Breakfast, Wednesday June 18, 2008, 7:30-9:00 a.m.
Hear what some of our previous attendees had to say:
“CBI staff was professional and very helpful. All speakers were top notch and I would sign up for future CBI courses/classes!”
– 2007 attendee, Michelle Cimo, Healthcare Compliance Manager, Johnson & Johnson, Ethicon
For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.
